Literature DB >> 25824857

Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upper abdominal surgery.

Pierluigi Benedetti Panici1, Violante Di Donato2, Margherita Fischetti1, Assunta Casorelli1, Giorgia Perniola1, Angela Musella1, Claudia Marchetti1, Innocenza Palaia1, Pasquale Berloco3, Ludovico Muzii1.   

Abstract

OBJECTIVE: To evaluate the complication rate and its impact in patients who have undergone upper abdominal surgery for treatment of advanced ovarian cancer.
METHODS: Patients who have undergone upper abdominal surgery including diaphragm surgery, splenectomy, distal pancreatectomy, gastric resection, liver resection and biliary surgery were considered for the study. Perioperative complications were evaluated and graded according to Clavien-Dindo.
RESULTS: One hundred and twenty one patients were included. Two hundred and twelve surgical procedures were performed. Thirty-six patients reported at least one complication, but 61.1% of these the complication was mild. Median hospital stay for patients with and without complication was 7 vs. 13days respectively (p<0.001). There was a significant correlation between post-operative hospital stay and the total number of surgical procedures (R=0.445, p<0.001). At multivariate analysis, diaphragmatic resection and pancreatic resection were associated with a significant increase of postoperative hospital stay, furthermore diaphragmatic resection (p=0.004), hepatic resection (p=0.004), pancreatectomy (p=0.011) and biliary surgery (p=0.049) were independent predictors of severe (G3-G4) complication.
CONCLUSIONS: Rate of complications of patients submitted to upper abdominal surgery for ovarian cancer is acceptable. Prediction of severe complications is the goal for its optimal management. Extensive procedures should be avoided with those patients in which optimal residual tumor could not be reached.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advanced ovarian cancer; Complication rate; Predictors of complication rate; Predictors of postoperative morbidity; Upper abdominal surgery

Mesh:

Year:  2015        PMID: 25824857     DOI: 10.1016/j.ygyno.2015.03.043

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  23 in total

1.  ASO Author Reflections: Ultra-Radical Resection in Ovarian Cancer: Where Are We and Where Are We Going?

Authors:  Pierluigi Benedetti Panici; Violante Di Donato
Journal:  Ann Surg Oncol       Date:  2020-08-09       Impact factor: 5.344

Review 2.  Lymphadenectomy in Ovarian Cancer: Is It Still Justified?

Authors:  Pierluigi Benedetti Panici; Andrea Giannini; Margherita Fischetti; Francesca Lecce; Violante Di Donato
Journal:  Curr Oncol Rep       Date:  2020-02-08       Impact factor: 5.075

3.  Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy.

Authors:  P Cascales Campos; L A Martinez Insfran; D Wallace; J Gil; E Gil; A Gonzalez Gil; J Martínez; J L Alonso Romero; R Gonzalez Sanchez; P Parrilla
Journal:  Clin Transl Oncol       Date:  2019-08-07       Impact factor: 3.405

4.  National trends in bowel and upper abdominal procedures in ovarian cancer surgery.

Authors:  Joseph A Dottino; Weiguo He; Charlotte C Sun; Hui Zhao; Shuangshuang Fu; Jose Alejandro Rauh-Hain; Rudy S Suidan; Karen H Lu; Sharon H Giordano; Larissa A Meyer
Journal:  Int J Gynecol Cancer       Date:  2020-07-02       Impact factor: 3.437

5.  Peri-operative blood management of Jehovah's Witnesses undergoing cytoreductive surgery for advanced ovarian cancer.

Authors:  Innocenza Palaia; Giuseppe Caruso; Violante Di Donato; Giorgia Perniola; Giancarlo Ferrazza; Enrico Panzini; Maria Scudo; Anna Di Pinto; Ludovico Muzii; Pierluigi Benedetti Panici
Journal:  Blood Transfus       Date:  2021-02-25       Impact factor: 3.443

Review 6.  Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.

Authors:  Shaun Hiu; Andrew Bryant; Ketankumar Gajjar; Patience T Kunonga; Raj Naik
Journal:  Cochrane Database Syst Rev       Date:  2022-08-30

7.  Risk factors of perioperative complications and management with enhanced recovery after primary surgery in women with epithelial ovarian carcinoma in a single center.

Authors:  Min Li; Tianjiao Zhang; Jing Zhu; Yuebo Li; Wenying Chen; Yanhu Xie; Wei Zhang; Rongzhu Chen; Wei Wei; Guihong Wang; Jiwei Qin; Weidong Zhao; Dabao Wu; Zhen Shen; Björn Nashan; Ying Zhou
Journal:  Oncol Lett       Date:  2022-03-16       Impact factor: 3.111

8.  Less guessing, more evidence in identifying patients least fit for cytoreductive surgery in advanced ovarian cancer: A triage algorithm to individualize surgical management.

Authors:  Deepa Maheswari Narasimhulu; Amanika Kumar; Amy L Weaver; Carrie L Langstraat; William A Cliby
Journal:  Gynecol Oncol       Date:  2020-04-01       Impact factor: 5.482

9.  Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse events.

Authors:  Alli M Straubhar; Jennifer L Wolf; Ms Qin C Zhou; Alexia Iasonos; Stephanie Cham; Jason D Wright; Kara Long Roche; Dennis S Chi; Oliver Zivanovic
Journal:  Gynecol Oncol       Date:  2020-12-04       Impact factor: 5.482

10.  Appropriate triage allows aggressive primary debulking surgery with rates of morbidity and mortality comparable to interval surgery after chemotherapy.

Authors:  Deepa M Narasimhulu; Aneesa Thannickal; Amanika Kumar; Amy L Weaver; Michaela E McGree; Carrie L Langstraat; William A Cliby
Journal:  Gynecol Oncol       Date:  2020-12-31       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.